Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 35788638.
- Also identified by DOI 10.1001/jamaneurol.2022.1735 and PMC identifier 9257675.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This systematic review and meta-analysis investigates the use of the bayesian approach to estimate the plausible effect of teriflunomide in children with multiple sclerosis.
Medical subject headings
- Multiple Sclerosis